+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Respiratory Disease Testing Market Research Report by Product (Blood Gas Test, Imaging Tests, and Respiratory Measurement), End-Use, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 251 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 4985882
UP TO OFF until Mar 31st 2023
The Global Respiratory Disease Testing Market size was estimated at USD 3,915.59 million in 2022, USD 4,083.30 million in 2023, and is projected to grow at a CAGR of 4.41% to reach USD 5,534.31 million by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Respiratory Disease Testing Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Respiratory Disease Testing Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Respiratory Disease Testing Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Respiratory Disease Testing Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Respiratory Disease Testing Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market is studied across Blood Gas Test, Imaging Tests, and Respiratory Measurement.
  • Based on End-Use, the market is studied across Clinical Laboratories, Hospitals, and Physician Clinics.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Respiratory Disease Testing Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Respiratory Disease Testing Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Respiratory Disease Testing Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Respiratory Disease Testing Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Respiratory Disease Testing Market, including Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Biomérieux, Cosmed, F. Hoffmann-La Roche Ltd., Fujifilm Holdings, GE Healthcare, Hitachi Medical Corporation, Koninklijke Philips N.V, Medtronic PLC, MGC Diagnostics Corporation by Caire Inc., ResMed, SDI Diagnostics, Inc., Seegene Inc., and Thermo Fisher Scientific.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Respiratory Disease Testing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Respiratory Disease Testing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Respiratory Disease Testing Market?
4. What is the competitive strategic window for opportunities in the Global Respiratory Disease Testing Market?
5. What are the technology trends and regulatory frameworks in the Global Respiratory Disease Testing Market?
6. What is the market share of the leading vendors in the Global Respiratory Disease Testing Market?
7. What modes and strategic moves are considered suitable for entering the Global Respiratory Disease Testing Market?
Frequently Asked Questions about the Global Respiratory Disease Testing Market

What is the estimated value of the Global Respiratory Disease Testing Market?

The Global Respiratory Disease Testing Market was estimated to be valued at $3915.59 Million in 2022.

What is the growth rate of the Global Respiratory Disease Testing Market?

The growth rate of the Global Respiratory Disease Testing Market is 4.4%, with an estimated value of $5534.31 Million by 2030.

What is the forecasted size of the Global Respiratory Disease Testing Market?

The Global Respiratory Disease Testing Market is estimated to be worth $5534.31 Million by 2030.

Who are the key companies in the Global Respiratory Disease Testing Market?

Key companies in the Global Respiratory Disease Testing Market include Abbott Laboratories, Becton, Dickinson and Company, Bio, Rad Laboratories, Inc., Biomérieux, Cosmed, F. Hoffmann, La Roche Ltd. and GE Healthcare.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of respiratory diseases
5.1.1.2. Adoption of unhealthy lifestyle and habits such as tobacco smoking
5.1.1.3. Constantly rising air pollution levels
5.1.1.4. Major adoption of imaging technology for diagnostics
5.1.2. Restraints
5.1.2.1. Availability of alternatives systems and devices
5.1.3. Opportunities
5.1.3.1. Rising preferences for remote or home care testing devices
5.1.3.2. R&D and technology advancements in testing methods for effective, efficient, and faster results
5.1.4. Challenges
5.1.4.1. Lack of supportive reimbursement policies
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Respiratory Disease Testing Market, by Product
6.1. Introduction
6.2. Blood Gas Test
6.3. Imaging Tests
6.4. Respiratory Measurement

7. Respiratory Disease Testing Market, by End-Use
7.1. Introduction
7.2. Clinical Laboratories
7.3. Hospitals
7.4. Physician Clinics

8. Americas Respiratory Disease Testing Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Respiratory Disease Testing Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Respiratory Disease Testing Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Product Portfolio Analysis, By Key Player
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.2. Becton, Dickinson and Company
12.3. Bio-Rad Laboratories, Inc.
12.4. Biomérieux
12.5. Cosmed
12.6. F. Hoffmann-La Roche Ltd.
12.7. Fujifilm Holdings
12.8. GE Healthcare
12.9. Hitachi Medical Corporation
12.10. Koninklijke Philips N.V
12.11. Medtronic PLC
12.12. MGC Diagnostics Corporation by Caire Inc.
12.13. ResMed
12.14. SDI Diagnostics, Inc.
12.15. Seegene Inc.
12.16. Thermo Fisher Scientific

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL RESPIRATORY DISEASE TESTING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RESPIRATORY DISEASE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RESPIRATORY DISEASE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL RESPIRATORY DISEASE TESTING MARKET DYNAMICS
FIGURE 11. GLOBAL RESPIRATORY DISEASE TESTING MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 13. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL RESPIRATORY DISEASE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 15. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, 2018-2030 (USD MILLION)
FIGURE 16. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
FIGURE 17. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, 2018-2030 (USD MILLION)
FIGURE 18. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
FIGURE 19. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 20. GLOBAL RESPIRATORY DISEASE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY END-USE, 2030
FIGURE 21. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
FIGURE 22. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 23. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PHYSICIAN CLINICS, 2018-2030 (USD MILLION)
FIGURE 24. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 25. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 26. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 27. AMERICAS RESPIRATORY DISEASE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 28. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 29. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 30. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 31. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 32. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 33. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 34. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 35. UNITED STATES RESPIRATORY DISEASE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 36. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 37. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 38. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 39. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 40. AUSTRALIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 41. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 42. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 43. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 44. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 45. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 46. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 47. SINGAPORE RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 48. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. TAIWAN RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. VIETNAM RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 56. DENMARK RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 57. EGYPT RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 58. FINLAND RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 59. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 60. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 61. ISRAEL RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 62. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 63. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 64. NIGERIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 65. NORWAY RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 66. POLAND RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 67. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 68. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 69. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 70. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 71. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 72. SWEDEN RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 73. SWITZERLAND RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 74. TURKEY RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 75. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 76. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 77. GLOBAL RESPIRATORY DISEASE TESTING MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 78. GLOBAL RESPIRATORY DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 79. GLOBAL RESPIRATORY DISEASE TESTING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022List of Tables
TABLE 1. GLOBAL RESPIRATORY DISEASE TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY BLOOD GAS TEST, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY RESPIRATORY MEASUREMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PHYSICIAN CLINICS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PHYSICIAN CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PHYSICIAN CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 36. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 37. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. CANADA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 39. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 40. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. MEXICO RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 49. ASIA-PACIFIC RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 53. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 54. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. CHINA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 56. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 57. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 58. INDIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 59. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 60. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 61. INDONESIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 62. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 63. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 64. JAPAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 65. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 66. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 67. MALAYSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 68. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 69. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 70. PHILIPPINES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 71. SINGAPORE RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 72. SINGAPORE RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. SINGAPORE RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 75. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. SOUTH KOREA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 77. TAIWAN RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 78. TAIWAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 79. TAIWAN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 80. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 81. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 82. THAILAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 83. VIETNAM RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 84. VIETNAM RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. VIETNAM RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 90. DENMARK RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 91. DENMARK RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 92. DENMARK RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 93. EGYPT RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 94. EGYPT RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. EGYPT RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 96. FINLAND RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 97. FINLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. FINLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 99. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 100. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. FRANCE RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 102. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 103. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 104. GERMANY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 105. ISRAEL RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 106. ISRAEL RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. ISRAEL RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 108. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 109. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 110. ITALY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 111. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 112. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. NETHERLANDS RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 114. NIGERIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 115. NIGERIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 116. NIGERIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 117. NORWAY RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 118. NORWAY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. NORWAY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 120. POLAND RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 121. POLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 122. POLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 124. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. QATAR RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 129. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 130. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. SAUDI ARABIA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 132. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 133. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. SOUTH AFRICA RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 135. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 136. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. SPAIN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 138. SWEDEN RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 139. SWEDEN RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 140. SWEDEN RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 141. SWITZERLAND RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 142. SWITZERLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. SWITZERLAND RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 144. TURKEY RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 145. TURKEY RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 146. TURKEY RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 152. UNITED KINGDOM RESPIRATORY DISEASE TESTING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 153. GLOBAL RESPIRATORY DISEASE TESTING MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 154. GLOBAL RESPIRATORY DISEASE TESTING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 155. GLOBAL RESPIRATORY DISEASE TESTING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 156. GLOBAL RESPIRATORY DISEASE TESTING MARKET RANKING, BY KEY PLAYER, 2022
TABLE 157. GLOBAL RESPIRATORY DISEASE TESTING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 158. GLOBAL RESPIRATORY DISEASE TESTING MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 159. GLOBAL RESPIRATORY DISEASE TESTING MARKET MERGER & ACQUISITION
TABLE 160. GLOBAL RESPIRATORY DISEASE TESTING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 161. GLOBAL RESPIRATORY DISEASE TESTING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 162. GLOBAL RESPIRATORY DISEASE TESTING MARKET INVESTMENT & FUNDING
TABLE 163. GLOBAL RESPIRATORY DISEASE TESTING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 164. GLOBAL RESPIRATORY DISEASE TESTING MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomérieux
  • Cosmed
  • F. Hoffmann-La Roche Ltd.
  • Fujifilm Holdings
  • GE Healthcare
  • Hitachi Medical Corporation
  • Koninklijke Philips N.V
  • Medtronic PLC
  • MGC Diagnostics Corporation by Caire Inc.
  • ResMed
  • SDI Diagnostics, Inc.
  • Seegene Inc.
  • Thermo Fisher Scientific

Methodology

Loading
LOADING...